Product Information

CHOLESTYRAMINE PACKET is a generic product labeled by Ascend Laboratories, LLC, priced at $0.8905 per EA under NDC 67877029860. Its NADAC has been published 245 times since Dec 22, 2021.

FDA first approved this application on Oct 19, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

CHOLESTYRAMINE PACKET

cholestyramine powder for suspension
$0.8905per EA

Strength

4 g/8.78g

NDC

67877029860

Classification

Generic

Dosage Form

POWDER, FOR SUSPENSION

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

CHOLESTYRAMINE

Approval Type

Generic (ANDA)

FDA Application

ANDA211856

FDA Approved

10/19/2021

TE Code

AB

On Market Since

10/20/2021

Pharmacological Classes

Bile Acid Sequestrant
Bile-acid Binding Activity

Price Statistics

The NADAC for CHOLESTYRAMINE PACKET has been published 245 times since Dec 22, 2021, and over the history we have for it it has declined 27.9%. The table below summarizes its recorded NADAC range and movement.

Current price$0.8905 per EA
All-time high$1.2760 (Feb 16, 2022)
All-time low$0.5806 (Apr 17, 2024)
52-week high$0.9309
52-week low$0.6721
Median price$0.8751
Average price$0.8841
Largest weekly change+34.2% (Jun 19, 2024)
Weeks tracked245
Tracking sinceDec 22, 2021

Price History

1W

-1.4%

1M

+6.7%

3M

+15.3%

6M

+11.9%

1Y

-5.2%

3Y

+31.5%

5Y

N/A

All

-27.9%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the cholestyramine powder for suspension market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of CHOLESTYRAMINE PACKET?

The current National Average Drug Acquisition Cost (NADAC) for CHOLESTYRAMINE PACKET, manufactured by Ascend Laboratories, LLC, is $0.8905 per EA (NDC 67877029860), effective Nov 18, 2026.

How has the price of CHOLESTYRAMINE PACKET changed over time?

Over the history we have for it, the NADAC for CHOLESTYRAMINE PACKET has declined 27.9%. It has been tracked across 245 weekly CMS publications since Dec 22, 2021.

What are the highest and lowest recorded NADAC prices for CHOLESTYRAMINE PACKET?

Since Dec 22, 2021, the NADAC for CHOLESTYRAMINE PACKET has ranged from a low of $0.5806 (Apr 17, 2024) to a high of $1.2760 (Feb 16, 2022), with a median of $0.8751 per EA.

Are there cheaper alternatives to CHOLESTYRAMINE PACKET?

No other NADAC-published product currently shares the active ingredient and strength of CHOLESTYRAMINE PACKET in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures CHOLESTYRAMINE PACKET?

CHOLESTYRAMINE PACKET (NDC 67877029860) is labeled by Ascend Laboratories, LLC, and CMS classifies it as a generic product.